ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 191 filers reported holding ARRAY BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $942,767,000 | +67.3% | 20,348,961 | -11.9% | 0.04% | +59.1% |
| Q1 2019 | $563,352,000 | +79.0% | 23,107,150 | +4.6% | 0.02% | +57.1% |
| Q4 2018 | $314,700,000 | -6.7% | 22,084,281 | -0.5% | 0.01% | +7.7% |
| Q3 2018 | $337,431,000 | -12.9% | 22,199,463 | -3.8% | 0.01% | -18.8% |
| Q2 2018 | $387,321,000 | +8.3% | 23,082,327 | +5.3% | 0.02% | 0.0% |
| Q1 2018 | $357,733,000 | +28.7% | 21,919,928 | +0.9% | 0.02% | +33.3% |
| Q4 2017 | $278,010,000 | +14.2% | 21,719,581 | +9.8% | 0.01% | +9.1% |
| Q3 2017 | $243,335,000 | +48.2% | 19,783,311 | +0.8% | 0.01% | +37.5% |
| Q2 2017 | $164,243,000 | +8.1% | 19,622,890 | +15.5% | 0.01% | 0.0% |
| Q1 2017 | $151,921,000 | +59.5% | 16,993,415 | +56.8% | 0.01% | +60.0% |
| Q4 2016 | $95,259,000 | +44.5% | 10,837,295 | +11.0% | 0.01% | +25.0% |
| Q3 2016 | $65,911,000 | +113.4% | 9,764,687 | +12.5% | 0.00% | +100.0% |
| Q2 2016 | $30,893,000 | +25.0% | 8,677,752 | +3.6% | 0.00% | 0.0% |
| Q1 2016 | $24,716,000 | -26.9% | 8,377,991 | +4.6% | 0.00% | 0.0% |
| Q4 2015 | $33,805,000 | -92.1% | 8,010,795 | -67.0% | 0.00% | -87.5% |
| Q3 2015 | $427,075,000 | +838.1% | 24,289,210 | +284.7% | 0.02% | +433.3% |
| Q2 2015 | $45,525,000 | +27.8% | 6,314,257 | +30.7% | 0.00% | +50.0% |
| Q1 2015 | $35,612,000 | +71.6% | 4,832,090 | +10.1% | 0.00% | +100.0% |
| Q4 2014 | $20,751,000 | +47.1% | 4,387,269 | +11.0% | 0.00% | 0.0% |
| Q3 2014 | $14,106,000 | -21.6% | 3,951,271 | +0.2% | 0.00% | 0.0% |
| Q2 2014 | $17,982,000 | -2.1% | 3,943,569 | +0.9% | 0.00% | -50.0% |
| Q1 2014 | $18,364,000 | -1.8% | 3,907,120 | +4.7% | 0.00% | 0.0% |
| Q4 2013 | $18,700,000 | -8.1% | 3,732,549 | +14.1% | 0.00% | 0.0% |
| Q3 2013 | $20,349,000 | +17.7% | 3,271,427 | -14.1% | 0.00% | 0.0% |
| Q2 2013 | $17,285,000 | – | 3,807,191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |